ISRG - Intuitive Surgical, Inc. Pick

a sunset view of a mountain range with clouds in the sky

Research brief

Oct 22, 2026 Morning

03:00 PM UTC

Intuitive Surgical, Inc. ISRG low

ISRG

Conf. Low

Pick Pr. $441.07

Stop Pr. $431.98

Curr. Pr. $443.85

Change +0.63%

Rem. Days 7

Summary

BUY ISRG — Momentum, Low confidence, retaining the decider's seven-calendar-day selection. The original research entry is $440.1099853516 at October 22, 2026, 12:40 ET; the independent publication quote is $441.2650146484 at 12:49 ET, not an executed fill. finance.yahoo
Released operating growth, not a pending earnings bet: the October 20 release reported worldwide procedures up 15% and an installed da Vinci base up 12%. Revenue growth of 21.70% is calculated from the issuer's reported figures. isrg.intuitiv
Decider estimates: original net expected return +0.2134%, versus −0.20% for matched-horizon SPY; expected excess +0.4134 percentage points. The 1.30-point uncertainty deduction leaves −0.8866% adjusted excess. These are fragile, uncalibrated forecasts, not promised returns.
Risk plan: authored stop $432, conditional stop-exit estimate $424, seven-day T1 $449.75, and original full-position profit barrier $457.462012. The barrier is not T1; stop confirmation and gaps can produce materially worse exits. These are decider-authored levels and calculations, not source-issued targets.
Freshness checks: the independently retrieved constituent list includes ISRG; the issuer calendar still lists no upcoming events. Neither that calendar nor the research establishes exhaustive court-event clearance. en.wikipedia.isrg.intuitiv

Why Now

Intuitive first disclosed its third-quarter results on October 20 at 16:05 ET. Revenue was $3,048.7 million, versus $2,505.1 million a year earlier; worldwide procedures rose 15%, da Vinci placements reached 546 versus 427, and the installed base reached 12,094, up 12%. These are released results, not anticipated announcements. isrg.intuitiv

Decider interpretation: procedure and installed-base growth support several sessions of earnings reassessment after the initial shock. The seven-day opportunity is additional price acceptance—not seven days of newly realized annual cash flow. Prior guidance and consensus revisions were not verified, so the recommendation does not rest on an asserted guidance raise or earnings beat.

The price response is a serious contradiction. From the supplied adjusted historical rows, the decider calculated an approximately 8.1% initial down-gap and an event range of 3.05 times pre-event ATR14. That activated mandatory post-shock confirmation rather than permitting a stop based on pre-event averages. The qualifying route was a completed October 22, 10:45–11:45 ET base, with low $438.73001, above the analyst-calculated regular-event-anchored VWAP. These are historical-data calculations, not fields established by the latest quote. finance.yahoo

The event anchor is October 21 at 09:30 ET, the first regular earnings-response opening. All 78 regular five-minute bars were included. The estimated event VWAP was $426.99955; placing the 606,825 unallocated shares, 12.64% of reported event-day volume, at daily extremes produced an upper bound of $427.61521. The base remained above that bound. Unknown overnight volume is not resolved by this test, and the anchor is not a claim of complete disclosure-time consolidated VWAP. The alternative first-following-session full-close support route was still pending. finance.yahoo

Independent publication check

Checks were completed by October 22, 12:50:52 ET. The refreshed constituent list explicitly contains ISRG / Intuitive Surgical; no source update timestamp was supplied, so this is a retrieval-time observation. en.wikipedia.

The refreshed quote was $441.2650146484 at 12:49 ET. Twelve consecutive completed regular-session five-minute bars ending 11:55–12:50 ET had a minimum low of $439.00, above the prospective $438.73001 base. The two newly completed bars ending 12:45 and 12:50 had lows $440.045 and $440.57. Their highs did not clear the retained $441.70 first resistance. The quote succeeded on its first attempt; no outage exception was used. finance.yahoo

Calculation, not a revised forecast: the publication quote is 0.2624% above the original research entry. Substituting only that price into the unchanged scenario formula leaves approximately +0.0541% net expected return. Because this is positive before the uncertainty deduction, it passes the v6 pre-uncertainty absolute-return gate, subject to all other eligibility checks. The cushion is narrow; its small size is a risk disclosure, not a separate return veto. This does not establish a newly synchronized rank, re-estimate any odds, or replace the original research entry. The final executable price must be checked again; if quote, event or support changes materially alter the economics or eligibility, request upstream decision repair and a new freeze rather than reuse stale arithmetic.

The issuer's refreshed event page says no upcoming events are available and lists the October 20 earnings call as past. This is limited calendar evidence, not proof that no legal or regulatory event can occur. isrg.intuitiv

Business And Market Context

Intuitive supplies the da Vinci surgical platform, the Ion lung-biopsy platform, instruments, accessories and related services. Its business therefore combines installed systems with ongoing procedure-related products and support. finance.yahoo Instruments and accessories generated $1,797.4 million of third-quarter revenue, supporting the adoption-based—not merely product-announcement—thesis. isrg.intuitiv

Financial resilience supports holding through normal volatility, but does not guarantee price appreciation. At September 30, 2026, reported cash, equivalents and investments were $6.8004 billion, versus total liabilities of $3.2313 billion. Adjusted gross margin was 69.9%, versus 68.0% a year earlier. isrg.intuitiv The research did not recover exact current operating cash flow, capital expenditure, free cash flow or interest-bearing borrowings; no debt-free or fully audited solvency claim is made.

Earnings quality deserves particular care. Adjusted EPS of $3.00 included $0.06 of tariff-refund benefit. The $450 million settlement is an issuer cash outflow, not income; its approval timing remains unresolved in the research. isrg.intuitivstocktitan.ne Simply subtracting the refund gives $2.94, an analyst calculation—not fully normalized earnings. Quarterly stock compensation of $216 million also remains an economic cost despite adjusted presentation. stocktitan.ne

The macro backdrop argues for caution rather than an automatic market veto. At the 12:40 ET decision freeze, SPY was $763.590027, below completed SMA20 $770.8805 and SMA50 $767.3502, but above SMA200 $723.2361. finance.yahoo Earlier equal-weight and defensive resilience was measured at earlier clocks; it is not synchronous publication-time breadth. No verified advance/decline count is available in the supplied evidence.

The scheduled October 28 FOMC decision at 14:00 ET and press conference at 14:30, followed by October 29 GDP and personal income/outlays, including PCE, at 08:30 ET, fall before the frozen maturity. These are shared market risks, not pending ISRG earnings. federalreservbea.gov Exact flash-PMI, ECB, next-claims and BoJ decision clocks were not fully verified upstream; the research does not claim an exhaustive macro calendar.

Portfolio context supplied with this assignment, not independently broker-verified: healthcare already represents 16.59% and technology 16.30% of the portfolio. ISRG is absent from the supplied active-public-position list; LLY and TMO already create healthcare exposure. A standard new slot is one-twelfth of the fund. This is a concentration penalty, not evidence of diversification. Current broker positions and recent closed holdings were not refreshed.

Factor Stack

Factor	Source-reported observation or research limitation	Decider interpretation
Catalyst/news	October 20 results: procedures +15%, installed base +12%, placements 546 versus 427. isrg.intuitiv	Released operating evidence supports reassessment; no verified guidance raise is assumed.
Growth/profitability	Revenue $3,048.7m; adjusted gross margin 69.9%; EPS includes a $0.06 refund. isrg.intuitiv	Growth is real, but refund and legal effects complicate earnings quality.
Financial health	Cash/investments $6.8004bn versus liabilities $3.2313bn at September 30. isrg.intuitiv	Resilience supports feasibility; missing exact FCF and borrowings limit confidence.
Valuation	Publication-refresh provider ratios: approximately 53.36× trailing and 35.56× forward earnings. finance.yahoo	Premium valuation is a downside sensitivity, not a seven-day floor.
Momentum/relative strength	Completed September 24–October 21 return +7.16%; matched SPY excess +6.39pp and XLV excess +1.82pp. finance.yahoo	Historical leadership helps, but does not prove forward alpha or current sector-adjusted outperformance.
Volume/extension	Current cumulative volume is displayed as 1.1m shares; completed daily average is 2.2m. finance.yahoo	A partial-day fraction is not pace-adjusted relative volume. The shock demands event-based support, not a moving-average shortcut.
Expert/community checks	An October 22 MarketBeat article favors a bottoming interpretation; an October 20 X earnings repost is bullish. marketbeatx	These are selective opinions, not representative sentiment. The article mislabels a procedure-growth guidance metric; the post's operating-income growth conflicts with issuer figures. Neither drives the odds.
Revisions/crowding	No verified current estimate-revision series or representative options/positioning sample was supplied.	No earnings-upgrade or uncrowded-trade claim is justified. Missing secondary evidence reduces certainty, not eligibility by itself.

Investment Thesis

1. Adoption can support further acceptance—but resistance still matters

Decider thesis: released procedure growth and the defended event base offer a better seven-day continuation proposition than company quality alone. The initial selloff and repeated resistance rejection are opposing evidence, not facts to explain away.

The $449.75 T1 is an authored seven-day reference anchored to supplied adjusted historical highs of $448.75 on May 11 and $449.769989 on May 20. Those historical observations support the level's provenance, not its probability of being reached. finance.yahoo

The nearer $441.70 first resistance remains a separate path diagnostic. At the original entry, T1 implies +2.190365%, whereas the actual full-position barrier is:

$440.1099853516 + 1.8 × ($449.75 − $440.1099853516) = $457.462012, or +3.942657%.

These are decider-input calculations. There is no full-position sale merely because T1 is touched. The original 20% profit-exit probability was decomposed into 65% assumed resistance clearance × 30.76923% assumed subsequent barrier exit. Multiplying subjective assumptions does not create empirical calibration. No dated seven-day policy-exit reference sample was available.

2. The original positive absolute return is small and sensitive

All following branches are mutually exclusive decider estimates, fixed at the original research entry:

Exit branch	Assumed probability	Conditional return before aggregate friction
Actual $457.462012 profit barrier causes exit	20%	+3.942657%
Confirmed stop causes exit, conditional estimated fill $424	25%	−3.660445%
Neither earlier exit; horizon exit	55%	+0.8%

Calculation: 0.20 × 3.942657 + 0.25 × (−3.660445) + 0.55 × 0.8 − 0.10 = +0.213420% net. The 0.10-percentage-point friction estimate includes the required 0.1% adverse exit slippage once; it assumes no additional commission/spread charge. Real costs may be larger. Early-exit proceeds remain cash without modeled interest until maturity.

The decider's strictly positive 1.30pp uncertainty deduction represents forecast uncertainty, not a guaranteed loss or a second execution charge. It leaves negative adjusted excess, which informs ranking and Low confidence; the governing eligibility test remains positive absolute net expected return before uncertainty, not a confidence threshold.

3. SPY and the best alternative use the same seven days

Decider SPY estimate: 30% relief / 40% range / 30% downside, with assumed gross price returns +1.6% / +0.2% / −2.2%, produces −0.10% gross, then −0.20% net after 0.10pp friction. These weights and returns are uncalibrated judgment informed by the dated market evidence, not reported market forecasts or trailing-return extrapolations.

The sponsor's schedule has no SPY ex-date inside October 22–29. The September distribution's October 30 payment date does not confer entitlement on an October 22 buyer; the matched forecast therefore assumes zero dividend return. ssga

Original full-gate rank	Candidate	Decider net EV	SPY excess	Uncertainty	Adjusted excess	Outcome
1	ISRG	+0.213420%	+0.413420pp	1.30pp	−0.886580pp	Selected
2	ADSK	+0.738279%	+0.938279pp	2.20pp	−1.261721pp	Positive, lower adjusted rank
3	ROL	+0.273921%	+0.473921pp	1.80pp	−1.326079pp	Positive, lower adjusted rank
4	ZTS	−0.099428%	+0.100572pp	1.50pp	−1.399428pp	Fails absolute-return gate
5	UAL	−0.014644%	+0.185356pp	1.90pp	−1.714644pp	Fails absolute-return gate
6	BR	−0.433767%	−0.233767pp	1.50pp	−1.733767pp	Fails absolute-return gate
7	CCI	−0.273034%	−0.073034pp	2.30pp	−2.373034pp	Fails absolute-return gate

These are frozen-input decider calculations, not source-reported forecasts or publication-time rerankings. All use October 22 12:40 ET to October 29 12:40 ET and the same policy.

ADSK is the strongest alternative, with higher base absolute return but a larger evidence-based uncertainty deduction. Its August 27 results reported revenue growth of 16%, operating cash flow $575 million and free cash flow $561 million. investors.au The decider penalized integration/pricing sensitivity and historical post-disclosure underperformance more heavily than ISRG's released operating delta; lack of fresh earnings alone was not a veto. Its retained screen rank is 17, not its full-gate rank of 2. finance.yaho

ROL ranks third, not falsely negative after its cheaper final quote. Its October 21 release showed organic growth 4.4%, adjusted margin down 140 basis points, EPS down 2.9%, and a $63 million tax-refund timing benefit to cash flow. rollins The decider treated normalized operating deterioration as a ranking penalty despite positive modeled return.

Numerical stress review

These are alternative decider forecasts, not calibrated worst cases. Entry, authored stop, T1, horizon and policy remain fixed.

Diagnostic	ISRG	ADSK
Base net / SPY excess	+0.2134% / +0.4134pp	+0.7383% / +0.9383pp
Adverse net / SPY excess	−1.0062% / −0.8062pp	−1.3665% / +0.0735pp
Profit→stop probability-shift headroom	2.806749pp	7.421547pp
Profit→time probability-shift headroom	6.790433pp	13.633039pp
Minimum uncertainty covering tested deterioration	1.2196pp	2.1048pp
Declared uncertainty / covers tested deterioration	1.30pp / true	2.20pp / true

For ISRG, the issuer-specific adverse case changes profit/stop/time odds to 14/32/54%, conditional stop exit to $420, conditional time return to +0.1%, and friction to 0.15%; SPY remains −0.20%. Resistance rejection, premium valuation, refund distortion and legal uncertainty motivate this challenge. isrg.intuitivstocktitan.nefinance.yahoo The numerical changes and resulting forecasts are decider assumptions/calculations.

For ADSK, the adverse inputs are 14/34/52%, stop exit $241.50, time return −0.8%, friction 0.15%, and coherently weaker SPY −1.44%. This combines shared growth/rate pressure with integration/pricing disappointment; it does not pair an adverse stock case with a favorable market. These are decider sensitivity assumptions. Both declared deductions already cover the tested deterioration once; subtracting it again would double count.

The ISRG base becomes nonpositive with only a 2.806749-point profit-to-stop probability shift, all else fixed. Its original fixed-assumption entry break-even is approximately $441.6584. These are mechanical sensitivity diagnostics—not calibrated odds, an approved limit order, or permission to ignore a changed quote/base.

Risks And Thesis Breakers

Broken event support. The actionable thesis relies on the prospective $438.73001 base. A breach or loss of qualifying structure requires upstream re-evaluation; no alternative completed full-session hold has been certified. This is a thesis condition, not a newly invented automatic execution stop. Current completed bars through 12:50 ET preserve the level. finance.yahoo
Confirmation-delayed exits and gaps. The authored $432 stop requires the trailing 60-minute average to remain below it for 120 minutes. The separate 15% hard-loss condition requires 10 minutes of confirmation. Neither assures a threshold fill. The decider's $424 conditional stop exit explicitly allows $8 leakage below the authored threshold; overnight or fast-market losses can be worse.
Unresolved legal timing. The settlement requires approval; the research did not verify approval or rehearing clocks. stocktitan.ne The refreshed investor calendar lists no upcoming events, but is not a court docket. isrg.intuitiv Evidence of an imminent scheduled gap-risk binary before an executable stop window would require decision repair, not an invented clearance.
Valuation and earnings-quality disappointment. Approximately 53.36× trailing and 35.56× forward provider P/E leave little protection from expectation compression. finance.yahoo Tariffs, a nonrecurring refund and settlement costs complicate the reported growth narrative. isrg.intuitiv Premium quality is not itself the seven-day edge.
Barrier travel can fail despite a T1 touch. The decider estimates only 20% actual profit-barrier exits. The initial down-gap and resistance rejection are the strongest price-based contradictions. No positive forecast is justified merely by touching T1 or temporarily clearing first resistance.
Shared macro and portfolio exposure. FOMC and GDP/PCE occur before maturity. federalreservbea.gov Supplied healthcare exposure is already 16.59%; this is not an isolated sector bet. Market weakness can impair both continuation and delayed stop fills.
Data and alternative-row limitations. Unknown overnight volume, bounded missing regular-event shares, missing exact FCF/borrowings, unverified revisions, selective sentiment and unrefreshed broker/closed-holding evidence constrain confidence. Two inherited alternate narratives conflict with their numeric inputs: ZTS says stop exit $77.20 versus authoritative $77.10; UAL says $94.20/time +0.6% versus authoritative $94.80/+1.1%. Those inconsistencies are disclosed, not repaired or used to change the selected scenario.

Other reviewed candidates and retained sixth alternative

The five structured alternatives retain full-gate ranks 2–6. The additional reviewed alternative below preserves full-gate rank 7 and its complete forecast inputs.

CCI — Crown Castle Inc.; full-gate rank 7; actionable numerical gate failure, not a hard rejection. Decider catalyst assessment: the October 21 AFFO/share guide rose only $4.59 to $4.60, the revenue increase reflected straight-line recognition, and billings were unchanged. investor.cro Entry quality was structurally actionable but economically lower-ranked.

Required CCI forecast input	Preserved value
Research entry / timestamp	79.50499725341797 / October 22, 12:40 ET finance.yaho
Authored stop / conditional stop-exit estimate	75.90 / 74.50
First resistance / seven-day T1	80.30 / 83.26
Profit / stop / time exit probabilities	12.5% / 27.0% / 60.5%
Conditional time-exit return / friction	+0.8% / 0.12%
Forecast horizon	7 calendar days
Execution policy	authoredstopma60confirm120hard15confirm10tp1p8_v1
Benchmark expected net return / uncertainty deduction	−0.20% / 2.30pp

All non-quote CCI values are decider estimates. Benchmark basis: the same 12:40-to-12:40 SPY forecast described above—30/40/30% at +1.6/+0.2/−2.2%, zero in-window dividend, less 0.10pp friction—supported by the frozen moving-average context and FOMC/GDP/PCE timing. finance.yahoofederalreservbea.govssga

CCI scenario basis: the decider retained support $76.29, stop $75.90, conditional delayed exit $74.50, historical-reference T1 $83.26 and R1 $80.30. Observed support and the modest guide change support the structure but not strong continuation. investor.crofinance.yaho Assumed 50% clearance × 25% subsequent actual-barrier exit gives 12.5%; stop/time probabilities remain 27/60.5%. The cheaper entry improves loss geometry but lengthens barrier travel. The decider's adverse 8/35/57% case uses stop $73.50, time −0.5%, friction 0.15%, SPY −1.44%; calculated net/excess are −2.398435%/−0.958435pp. Minimum uncertainty 2.125401pp is covered by declared 2.30pp. These are uncalibrated assumptions, not source forecasts.

Three other fully researched names had current mandatory-trigger/broken-support gates, without fabricated scenarios:

LMT: at 12:40 ET, $579.980896 was below opening-response VWAP $589.0611; the latest twelve completed bars did not supply the mandatory base. The October 23 alternative full-session $577.23999 support hold was not complete. Buying before confirmation could not use pre-event averages as replacement support. finance.yaho
SMCI: at 12:40 ET, $33.470001 remained below the prospectively defined $35.14 event support, already breached by an earlier $33.11 low. No newly validated event base replaced it. finance.yaho
CRL: at 12:40 ET, $341.739990 was below mandatory base $346.98001 and authored stop $345.80; the completed 12:35–12:40 bar low was $342.40. The old stop was therefore above a new entry and infeasible. finance.yaho

The decider reviewed ten finalists and retained three positive initial candidates; an additional generation round was not triggered. This is a selected-stock report, not an audited stock N/A or a separate VOO-versus-cash allocation decision.

Investment Recommendation

Retain BUY ISRG, Momentum, Low confidence, under the unchanged seven-calendar-day execution contract. The source-backed operating delta and defended post-event base support the decider's choice; premium valuation, negative initial reaction, legal timing gaps and a very small residual modeled return argue against interpreting it as a high-conviction bargain.

Preserve the original research forecast at $440.1099853516, not the later quote as though it were the same entry. The publication-check quote is $441.2650146484 at October 22, 12:49 ET. finance.yahoo At that quote, the unchanged-assumption diagnostic gives approximately +0.0541% net expected return before uncertainty, so it passes the v6 absolute-return gate, subject to all other eligibility checks. This calculation leaves a very narrow cushion; it is not refreshed empirical support, a new ranking or a failed return gate. Preserve the authoritative BUY decision and scenario assumptions. If subsequent quote, event or support changes materially alter the economics or eligibility, request upstream decision repair and a synchronized re-freeze rather than infer a new decision from stale arithmetic.

The $432 authored stop and $424 conditional stop-exit estimate remain distinct. Apply the trailing-60-minute-average/120-minute confirmation and 15%-loss/10-minute hard confirmation exactly, with 0.1% adverse slippage, possible gaps and no promise of an exact fill. T1 remains $449.75; the original full-position barrier is $457.462012, not T1. Do not add discretionary trims, a different trailing rule or a longer hold.

The frozen research maturity and first liquid horizon exit are October 29, 2026, 12:40 ET. Actual execution has not been observed: an actual October 22 entry matures exactly seven calendar days later at its actual entry clock, with the first liquid executable exit window applied if needed. Re-freeze exact entry/maturity together rather than treating the research clock as an executed fill. Early-exit proceeds remain cash through maturity; the horizon is not extended for a hoped-for recovery.